This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
5 Jul 2011

EMA Welcomes EU New Legislation on Falsified Medicines

The new laws aim to prevent falsified medicines entering the legal supply chain and reaching patients.

The European Medicines Agency has welcomed the new Directive on falsified medicines, published in the Official Journal of the European Union on Friday 1 July.

 

The new laws aim to prevent falsified medicines entering the legal supply chain and reaching patients. They will do this by introducing harmonised safety and strengthened control measures across Europe, including:

1. obligatory features on the outer packaging of medicines to demonstrate that they are authentic;
2. strengthened requirements for the inspection of the manufacturers of pharmaceutical ingredients;
3. the obligation for manufacturers and distributors to report any suspicion of falsified medicines;
4. an obligatory logo that must be placed on the websites of legally operating on

Related News